Cigna Group

Cigna Group(CI)股票分析

$306.950

-8.687 (-2.83%)收盘时

Loading chart…
最高
315.860
开盘
314.750
成交量加权均价
309.44
成交量
1.78M
市值
94.92B
最低
305.510
成交额
550.95M
企业价值/息税折旧摊销前利润(TTM)
7.23

The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.

AI 分析 of Cigna Group (CI)

买入

Cigna Group (CI) is a good buy right now, as it is currently priced at $302.30, with a forward P/E ratio of 8.26, which is significantly lower than the market average, suggesting undervaluation. Additionally, the RSI is at 90.61, indicating strong momentum. However, the main risk is the insider selling activity, which has increased by 4982.25% over the last month, suggesting potential concerns about future performance.

分析师评级(17)

上行空间 +9.34%
买入
13 买入
4 持有
0 卖出
当前: 306.95
最低
300.00
平均
335.63
最高
378.00

Evercore ISI

2026-09-09

目标价

$290

In Line

Jefferies

2026-08-04

目标价

$307

持有

Raymond James

2026-08-03

目标价

$320

跑赢大盘

Deutsche Bank

2026-07-31

目标价

$305

持有

Baird

2026-07-31

目标价

$362

跑赢大盘

估值指标

Cigna Group(CI)当前预期市盈率为 8.26,5 年平均预期市盈率为 10.57。

预期市盈率

低估
5 年均值 P/E
10.57
当前P/E
8.26
高估
11.82
低估
9.33

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
8.57
当前EV/EBITDA
7.23
高估
9.83
低估
7.31

预期市销率

低估
5 年均值 P/S
0.37
当前P/S
0.27
高估
0.45
低估
0.29

Alphio AI 对 CI 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%CI

$391.81

情景价格

基

基准

基准 · 50%CI

$315.61

情景价格

悲

悲观

悲观 · 25%CI

$234.22

情景价格

持有 CI 的大户

H

Hotchkis and Wiley Capital Management, LLC

+ 持有CIELV

+9.79%

3个月收益率

T

Towers Watson Investment Management Limited

+ 持有CI

+9.42%

3个月收益率

G

GQG Partners, LLC

+ 持有CI

+9.35%

3个月收益率

C

Cbus Industry Superannuation Fund

+ 持有CI

+7.89%

3个月收益率

T

Trinity Street Asset Management LLP

+ 持有CI

+7.32%

3个月收益率

L

Lakewood Capital Management, LP

+ 持有CI

+5.19%

3个月收益率

事件时间线

2026-10-08 (ET)

20:00:00

Nasdaq Composite Falls 1.3% as Tech Stocks Struggle

2026-09-30 (ET)

07:30:00

The Cigna Group Launches $3B Modernization Initiative

07:30:00

Cigna FY26 Revenue Expected at About $280B

07:30:00

Targets Adjusted: 10%-14% Adjusted EPS CAGR

2026-09-23 (ET)

10:00:00

Lockheed Martin Awarded $1.2 Billion Army Contract

资讯

CI 常见问题 —— 由 Alphio AI 解答

The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Cigna Group (CI) is a good buy right now, as it is currently priced at $302.30, with a forward P/E ratio of 8.26, which is significantly lower than the market average, suggesting undervaluation. Additionally, the RSI is at 90.61, indicating strong momentum. However, the main risk is the insider selling activity, which has increased by 4982.25% over the last month, suggesting potential concerns about future performance.

17 analysts cover CI: 13 rate it Buy, 4 Hold and 0 Sell. The average price target is 335.63.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易